ALTEROLA BIOTECH INC. Quarterly Income Tax Expense (Benefit) in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Alterola Biotech Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q3 2024.
  • Alterola Biotech Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Alterola Biotech Inc. annual Income Tax Expense (Benefit) for 2020 was $82.5K, unchanged from 2019.
  • Alterola Biotech Inc. annual Income Tax Expense (Benefit) for 2019 was $82.5K, a 361% increase from 2018.
  • Alterola Biotech Inc. annual Income Tax Expense (Benefit) for 2018 was $17.9K, a 22.2% decline from 2017.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-29
Q2 2024 $0 Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-11-25
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-29
Q4 2020 $21.1K +$15.7K +291% Oct 1, 2020 Dec 31, 2020 10-Q 2021-05-28
Q4 2019 $5.4K -$12.5K -69.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-05-28
Q4 2018 $17.9K +$15.9K +796% Oct 1, 2018 Dec 31, 2018 10-Q 2020-12-29
Q4 2017 $2K Oct 1, 2017 Dec 31, 2017 10-Q 2020-12-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.